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March 2011880 Abstractstotal of 2014 PICCs were inserted during 1879 distinct hospitalizations in
1728 distinct patients, yielding a total of 15,115 days of PICC placement.
Most catheters were placed in the right arm (76.9%), and most were placed
in the basilic vein (74%). Most were double-lumen 5F (75.3%). Of the 2014
PICC insertions 60 in 57 distinct patients (3%) developed DVT in the
cannulated or adjacent veins. Factors associated with PICC associated DVT
included prior DVT (odds ratio [OR], 9.92; P .001), use of double-lumen
5F catheters (OR, 7.54; P .05), triple-lumen 6F catheters (OR, 19.5; P
.01), and prior surgery duration 1 hour (OR, 1.66; P  .1).
Comment: Assessment for DVT in the patients in this study occurred
only in symptomatic patients. Therefore, the actual true incidence of PICC-
associated DVT is likely to be much higher than that documented. It is
doubtful the clinical correlates associated with PICC-induced DVT (prior
DVT and surgery lasting1 hour) will have much impact on the selection of
patients for PICC placement. Physicians may, however, choose to treat
patients with these identified correlates with enhanced prophylaxis after
PICC placement. The data would also suggest it is important to minimize
the size of the catheter to reduce the development of symptomatic PICC-
associated DVT.
Short-term Outcome After Stenting Versus Endarterectomy for Symp-
tomatic Carotid Stenosis: A Preplanned Meta-analysis of Individual
Patient Data
The Carotid Stenting Trialists’ Collaboration. Lancet 2010;376:1062-73.
Conclusion: Stenting for symptomatic internal carotid artery (ICA)
stenosis should be avoided in patients aged70 years but might be as safe as
carotid endarterectomy (CEA) in younger patients with symptomatic ICA
stenosis.
Summary: Three large government-sponsored European trials—the
Endarterectomy versus Angioplasty in Patients with Symptomatic Severe
Carotid Stenosis (EVA- 3S) trial, the Stent-Protected Angioplasty versus
Carotid Endarterectomy (SPACE) trial, and the International Carotid
Stenting Study (ICSS)—evaluated CEA vs carotid artery stenting (CAS) in
symptomatic patients with standard surgical risk. These trials indicated a
higher periprocedural risk of stroke with CAS than with CEA. However, the
number of patients in each trial was insufficient to establish the relative
merits of stenting vs endarterectomy in relevant subgroups of patients. The
i
anvestigators of EVA-3S, SPACE, and ICSS therefore established the Ca-
otid Stenting Trialists’ Collaboration anticipating a meta-analysis to com-
are the safety and efficacy of CEA and CAS in predefined subgroups of
atients from the trials. The pooled data of 3433 patients with symptomatic
CA stenosis was analyzed with fixed effect binomial regression models
djusted for source trial. The primary outcome event was any stroke or
eath. Intention-to-treat and per-protocol analyses were performed. Pa-
ient-specific variables analyzed included age, sex, diabetes, hypertension,
ype of recent ipsilateral ischemic event, degree of ipsilateral carotid stenosis,
he presence of contralateral severe carotid stenosis or occlusion, and other
ariables.
The intention-to-treat analysis showed that in the first 120 days after
andomization, the primary end point of any stroke or death occurred
ignificantly more often in the CAS group (153 of 1725 [8.9%]) than in the
EA group (99 of 1708 [8.9%]; RR, 1.53, 95% CI, 1.20-1.95; P .0006).
he absolute risk difference was 3.2% (1.4%-4.9%). Age was the only
ubgroup variable analyzed that effected the risk of stroke in the CAS vs CEA
atients. In patients aged70 years, the estimated 120-day risk of stroke or
eath was 50 of 869 patients (5.8%) in the CAS group and 48 of 843 (5.7%)
n the CEA group (RR, 1.0; 95%CI, 0.68-1.47). In patients aged70 years,
stimated risk of CAS was twice that of CEA (103 of 856 [12.0%] vs 51 of
65 [5.9%]; RR, 2.4; 95% CI, 1.48-2.82; categoric interaction P  .0053,
rend interaction P  .0014). In the per-protocol analysis, risk estimates of
troke or death30 days of treatment among patients70 years were 43 of
51 patients (5.1%) in the CAS group and 37 of 821 patients (4.5%) in the
EA group (RR, 1.11; 95% CI, 0.73-1.71). For those aged 70 years,
stimates were 87 of 823 patients (10.5%) in the CAS group and 36 of 824
atients (4.4%) in the CEA group (RR, 2.41; 95% CI, 1.65-3.51; categoric
nteraction P  .0078, trend interaction P  .0013).
Comment: The European investigators showed significant insight in
he planning of this preplanned meta-analysis. These data, in combination
ith the recently reported CREST data, strongly suggest CEA is the
referred treatment for patients with symptomatic carotid stenosis who are
ged 70 years. It is important to remember, however, that the data apply
nly to patients at standard surgical risk. These are short-term data, and the
elative efficacy of the two procedures for long-term stroke prevention both
n symptomatic and asymptomatic patients was not addressed by this meta-
nalysis.
